Skip to main content
رجوع
Watch Compare

Dogwood Therapeutics, Inc.

جودة البيانات: 83%
DWTX
Nasdaq Manufacturing Chemicals
KWD 2.00
▲ KWD 0.06 (3.09%)
القيمة السوقية: 66.59 M
السعر
KWD 2.00
القيمة السوقية
66.59 M
نطاق اليوم
KWD 1.97 — KWD 2.11
نطاق 52 أسبوعًا
KWD 1.77 — KWD 9.50
حجم التداول
37,586
فتح KWD 2.06
متوسط 50 يوم / 200 يوم
KWD 2.82
29.07% below
متوسط 50 يوم / 200 يوم
KWD 4.60
56.49% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -15.62 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-484.66%
أقل من متوسط القطاع (-53.41%)
ROIC-23.99%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio4.49
Interest CoverageN/A

التقييم

PE (TTM)
-1.94
أقل من متوسط القطاع (-1.48)
P/B Ratio9.17
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -1.9 -1.5
P/B 9.2 1.6
ROE % -484.7 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -34.26 M
ROE -484.66% ROA -36.31%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -15.62 M
ROIC -23.99% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.49
Interest Coverage N/A Asset Turnover N/A
Working Capital 9.06 M Tangible Book Value -72.87 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.94 Forward P/E N/A
P/B Ratio 9.17 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -23.45%
Market Cap 66.59 M Enterprise Value 56.46 M
Per Share
EPS (Diluted TTM) -7.13 Revenue / Share N/A
FCF / Share -0.47 OCF / Share -0.47
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 45.59%
SBC-Adj. FCF -15.96 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -34.26 M -12.35 M -5.30 M -12.25 M -15.96 M
EPS (Diluted) -7.13 -12.52 -0.28 -1.11 -1.92
Gross Profit — — — — —
Operating Income -27.97 M -12.23 M -5.45 M -12.32 M -15.64 M
EBITDA — — — — —
R&D Expenses 21.87 M 3.53 M 1.73 M 8.07 M 10.80 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — 150,904.0 67,475.0 5,672.0
Income Tax 221,096.0 -503.0 — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 90.17 M 94.31 M 4.17 M 8.37 M 15.78 M
Total Liabilities 15.27 M 30.03 M 358,548.0 1.04 M 1.28 M
Shareholders' Equity 74.90 M -10.12 M 3.81 M 7.33 M 14.50 M
Total Debt — — — — —
Cash & Equivalents 6.52 M 14.85 M 3.32 M 7.03 M 14.01 M
Current Assets 8.43 M 16.54 M 4.17 M 8.37 M 15.78 M
Current Liabilities 3.06 M 3.18 M 358,548.0 1.04 M 1.28 M